FDA Inspection
FujiFilm Diosynth Biotechnologies U.S.A., Inc.FujiFilm Diosynth Biotechnologies U.S.A., Inc. – FDA Inspection, Feb 10, 2023
Record Details
This FDA Inspection record concerns FujiFilm Diosynth Biotechnologies U.S.A., Inc., with an inspection on February 10, 2023, issued by the Atlanta District Office.
- Inspection Date
- February 10, 2023
View Company Profile
ID · 035d17a5-a3b7-4197-92cb-73d777622338
Inspection Facts
- Inspection number
- 1218019
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of FujiFilm Diosynth Biotechnologies U.S.A., Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | Not classified | Atlanta District Office | |
| March 1, 2019 | Not classified | Atlanta District Office | |
| October 26, 2018 | Not classified | Atlanta District Office | |
| February 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for FujiFilm Diosynth Biotechnologies U.S.A., Inc.
- FDA Inspection 1309990 - 2026-03-27
- FDA Inspection 1092044 - 2019-03-01
- FDA Inspection 1080402 - 2018-10-26
- FDA Inspection 1045267 - 2018-02-09
- FDA Inspection 989406 - 2016-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.